Vmn1r139 Activators
Vmn1r139 activators belong to a diverse chemical class designed to modulate the function of the vomeronasal 1 receptor subtype 139, a receptor that plays a role in the detection of pheromonal signals and can have various influences on intracellular signaling mechanisms. The chemical makeup of these activators is not uniform; instead, it spans a wide range of molecular structures and functionalities, each tailored to interact with the biological systems in different ways. These compounds typically exert their effects by binding to the receptor or by altering the receptor's cellular environment, thereby modulating its activity. Some activators directly interact with the receptor's binding site, while others influence receptor function indirectly by altering the levels of intracellular secondary messengers or by modulating the activity of enzymes that are part of the receptor's signaling cascade.
The mechanisms of action for Vmn1r139 activators are quite varied, reflecting the complexity of cellular signaling pathways. For example, certain activators work by increasing the concentration of intracellular calcium, which serves as a ubiquitous secondary messenger mediating a variety of physiological processes, including signal transduction pathways involving the Vmn1r139 receptor. Others, such as forskolin, elevate the levels of cyclic AMP (cAMP), another pivotal secondary messenger that can enhance receptor activity by promoting phosphorylation events within the cell. By increasing cAMP, these activators indirectly promote the activity of protein kinase A (PKA), which can phosphorylate target proteins and bring about changes conducive to receptor activation. Some activators prevent the breakdown of cAMP by inhibiting phosphodiesterase enzymes, thus sustaining the receptor's activation state. Additional members of this chemical class may employ different strategies, such as mimicking endogenous ligands or altering membrane lipid dynamics, which can have downstream effects on the receptor's conformation and signaling efficacy.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $465.00 | ||
GTPγS is a non-hydrolyzable analog of GTP that can lock G-proteins in an active state. By preventing GTP hydrolysis, GTPγS can enhance signal transduction pathways related to G-protein-coupled receptors like vomeronasal 1 receptor 139, leading to prolonged receptor activation. | ||||||
Phorbol | 17673-25-5 | sc-253267 | 5 mg | $270.00 | 1 | |
Phorbol esters, such as phorbol 12-myristate 13-acetate (PMA), act as diacylglycerol (DAG) analogs and activate protein kinase C (PKC). PKC activation can lead to phosphorylation and enhancement of signaling pathways associated with vomeronasal 1 receptor 139. | ||||||
Bradykinin (1-3) | 23815-91-0 | sc-391193 sc-391193A sc-391193B | 5 mg 25 mg 100 mg | $154.00 $453.00 $1393.00 | ||
Bradykinin acts on its receptors which can trigger the phospholipase C pathway, leading to the production of DAG and IP3. This can lead to an increase in intracellular calcium and activation of PKC, indirectly enhancing the functional activity of vomeronasal 1 receptor 139 by modulating the cellular environment and signaling cascades related to receptor activation. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine can interact with its G-protein-coupled receptors to initiate a cascade of intracellular events, including the activation of phospholipase C and changes in intracellular calcium levels. This can indirectly enhance the functional activity of vomeronasal 1 receptor 139 by priming the receptor's signaling environment. | ||||||
Serotonin hydrochloride | 153-98-0 | sc-201146 sc-201146A | 100 mg 1 g | $118.00 $187.00 | 15 | |
Serotonin binds to its G-protein-coupled receptors, some of which activate adenylate cyclase and thereby increase cAMP levels. This rise in cAMP can lead to the activation of PKA and downstream phosphorylation events that can enhance the functional activity of vomeronasal 1 receptor 139. | ||||||
ADP | 58-64-0 | sc-507362 | 5 g | $54.00 | ||
ATP, through purinergic receptors, can lead to the activation of various intracellular signaling cascades, including the rise of intracellular calcium levels and kinase activity, potentially enhancing the functional activity of vomeronasal 1 receptor 139 by modulating signaling pathways associated with the receptor. | ||||||